(1H-Indazol-3-yl)methanamine dihydrochloride is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active compounds. It serves as a key intermediate in the creation of small molecule inhibitors targeting various enzymes and receptors. This compound is often explored for its potential in designing drugs for cancer therapy, as it can be incorporated into molecules that modulate signaling pathways involved in tumor growth and proliferation. Additionally, it is investigated for its role in developing treatments for inflammatory and autoimmune diseases due to its ability to interact with specific biological targets. Researchers also study its derivatives for potential applications in neurological disorders, where modulation of certain receptors or enzymes could provide therapeutic benefits. Its versatility in medicinal chemistry makes it a valuable tool for discovering novel therapeutic agents.